SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar SqwiiTrader (< 20) Submitted: 10/28/2013 6:52:12 AM : Underperform Start Price: $4.73 SCLN Score: +5.23

TOS HS pattern

Featured Broker Partners


Advertisement